United Kingdom-Cardiff: CLI-STA-52156 Professional Blood Glucose Testing Strips, Consumables and QC Material

Type of document: Contract Notice
Country: United Kingdom
Publication Ref: (2022/S 000-036728/EN)
Nature of contract: Supply contract
Procedure: Award of a contract without prior publication
Type of bid required: Not applicable

Voluntary ex ante transparency notice
Supplies

Section I: Contracting authority
I.1) Name and addresses
Official name: NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust)
Postal address: 4-5 Charnwood Court,, Heol Billingsley, Parc Nantgarw
Town: Cardiff
Postal code: CF15 7QZ
Country: United Kingdom
Contact Person: Rachel Evans
Telephone: +44 1443848585
Email: rachel.evans41@wales.nhs.uk
Internet address(es):
Main address:
Address of the buyer profile:

I.4) Type of the contracting authority
Body governed by public law
I.5) Main activity
Health

Section II: Object
II.1) Scope of the procurement
II.1.1) Title: CLI-STA-52156 Professional Blood Glucose Testing Strips, Consumables and QC Material
II.1.2) Main CPV code: 33696200
II.1.3) Type of contract Supplies
II.1.4) Short Description:
Supply of Professional Blood Glucose Testing Strips, Consumables and QC Material.
II.1.6) Information about lots
The contract is divided into lots: no
II.1.7) Total value of the procurement(excluding VAT)
Value:217716.80
Currency:GBP
II.2) Description
II.2.3) Place of performance
Nuts code: Main site or place of performance:CTM UHB region

II.2.4) Description of the procurement
Blood glucose monitoring refers to testing the concentration of glucose in the blood to aid the management of Diabetes types 1 & 2. Similarly, monitoring the presence of ketones in the blood is also important as high levels can result in complications such as Ketoacidosis.
This notice is to extend the current arrangement with Abbott Laboratories Ltd whilst a competitive tender is undertaken.

II.2.5) Award criteria
II.2.11) Information about options
Options: no
II.2.13) Information about European Union funds
The procurement is related to a project and/or programme financed by European Union funds: no
Section IV: Procedure
IV.1) Description
IV.1.1) Type of procedure
Award of a contract without prior publication of a call for competition in the Official Journal of the European Union in the cases listed below
(please complete point 2 of the Annex D)
IV.1.8) Information about the Government Procurement Agreement(GPA)
The procurement is covered by the Government Procurement Agreement: no
IV.2) Administrative information

Section V: Award of contract/concession
V.2) Award of contract/concession
V.2.1) Date of conclusion of the contract/concession award decision:2022-12-30
V.2.2) Information about tenders
V.2.3) Name and address of the contractor
Official name: Abbott Laboratories
Postal address: Abbott House, Vanwall Business Park, Vanwall Road
Town: Maidenhead
Postal code: SL64XE
Country: United Kingdom
Nuts code:
The contractor is an SME: no

V.2.4) Information on value of the contract/lot/concession(excluding VAT)
for framework agreements – total maximum value for this lot
for contracts based on framework agreements, if required – value of contract(s) for this lot not included in
previous contract award notices

Section VI: Complementary information
VI.3) Additional information:
(WA Ref:127807)
VI.4) Procedures for review
VI.4.1) Review body
Official name: High Court
Postal address: Royal Courts of Justice, The Strand
Town: London
Postal code: WC2A 2LL
Country: United Kingdom
Telephone: +44 2079477501

VI.5) Date of dispatch of this notice:
2022-12-30

Other justification for the award of the contract without prior publication of a call for competition
in the Official Journal of the European Union
The procurement falls outside the scope of application of the directive

3.Explanation
Please explain in a clear and comprehensive manner why the award of the contract without prior publication in the Official Journal of the European Union
is lawful, by stating the relevant facts and, as appropriate, the conclusions of law in accordance with the directive:
The contract with Abbott Laboratories Ltd ended on 30th September 2021. A 12 month agreement was sought to allow sufficient time for NWSSP Procurement Services to undertake a competitive procurement however, due to various factors it has not been possible to complete this therefore an additional 6 months plus 6 months extension period has been sought.
The Health Board cannot find a Public Sector Framework with which to engage with Abbott Laboratories Ltd at this time and therefore, there is no opportunity to make a compliant direct award.
For the reasons outlined above and to ensure continuity of service for patient care, the Health Board has no option but to enter into a 12-month agreement without any formal underpinning Framework arrangement.